https://doi.org/10.4081/reumatismo.2016.897
Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?
Submitted: 7 July 2016
Accepted: 5 October 2016
Published: 16 December 2016
Accepted: 5 October 2016
Abstract Views: 1525
PDF: 1049
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Mencarini, J., Spinicci, M., & Bartalesi, F. (2016). Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?. Reumatismo, 68(3), 144–147. https://doi.org/10.4081/reumatismo.2016.897
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- D. Diacinti, C. Gioia, F. Vullo, G. Cannavale, C. Catalano, G. Valesini, Magnetic resonance imaging findings of infectious sacroiliitis associated with iliopsoas abscess: a case report in a young male , Reumatismo: Vol. 70 No. 4 (2018)
- C.U. Manzini, M. Colaci, C. Ferri, E. Manzini, Paraneoplastic rheumatic disorders: a narrative review , Reumatismo: Vol. 70 No. 4 (2018)
- A.A. Conti, D. Lippi, G.F. Gensini, The historical evolution of the concept of apoptosis in rheumatic diseases , Reumatismo: Vol. 57 No. 1 (2005)
- F. Carubbi, A. Alunno, R. Gerli, R. Giacomelli, Histopathology of salivary glands , Reumatismo: Vol. 70 No. 3 (2018): Monographic issue on Histopathology in Rheumatic Diseases
- F. Salaffi, A. Stancati, M. Carotti, R. Lorenzetti, W. Grassi, The impact of vertebral fractures on quality of life in postmenopausal women with osteoporosis. Validity of the Italian version of mini-Osteoporosis Quality of Life Questionnaire , Reumatismo: Vol. 57 No. 2 (2005)
- M. Rossini, P. Piscitelli, F. Fitto, P. Camboa, A. Angeli, G. Guida, S. Adami, Incidence and socioeconomic burden of hip fractures in Italy , Reumatismo: Vol. 57 No. 2 (2005)
- M. Benucci, F. Li Gobbi, A. Del Rosso, M. Manfredi, Systemic lupus erythematosus: the first italian prevalence study , Reumatismo: Vol. 57 No. 2 (2005)
- A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco, Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab , Reumatismo: Vol. 58 No. 2 (2006)
You may also start an advanced similarity search for this article.
